Insights

Innovative CNS Solutions NeuroDerm specializes in developing drug-device combination therapies for central nervous system disorders, presenting opportunities to collaborate with healthcare providers and pharmaceutical partners focusing on neurodegenerative and psychiatric conditions.

Recent Acquisition Momentum Having been acquired by Mitsubishi Tanabe Pharma for 1.1 billion USD, NeuroDerm is positioned for expansion and increased market penetration, making it a strategic partner for companies seeking to access CNS treatment innovations.

Growing R&D Focus As an active clinical-stage company with a robust pipeline and recent regulatory engagements, NeuroDerm offers potential for co-development opportunities with firms interested in advanced drug delivery systems and innovative CNS therapies.

Financial Scale and Funding With revenue estimates between 50 to 100 million USD and additional funding of 75 million USD, NeuroDerm presents a stable yet growth-oriented prospect for partners and investors in biotech and pharmaceutical tech sectors.

Market & Regulatory Engagements Recent approvals and regulatory advice from the EMA indicate a company engaged with European health authorities, providing a pathway for partners to explore international market expansion and compliance-focused collaborations.

NeuroDerm Ltd. Tech Stack

NeuroDerm Ltd. uses 8 technology products and services including Cloudflare CDN, MySQL, Apple iCloud Mail, and more. Explore NeuroDerm Ltd.'s tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • MySQL
    Database
  • Apple iCloud Mail
    Email
  • Twemoji
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • Swiper
    Javascript Libraries
  • WhatsApp Business
    Live Chat
  • PWA
    Miscellaneous

Media & News

NeuroDerm Ltd.'s Email Address Formats

NeuroDerm Ltd. uses at least 1 format(s):
NeuroDerm Ltd. Email FormatsExamplePercentage
First@neuroderm.comJohn@neuroderm.com
85%
Last@neuroderm.comDoe@neuroderm.com
8%
FirstL@neuroderm.comJohnD@neuroderm.com
4%
FLast@neuroderm.comJDoe@neuroderm.com
3%

Frequently Asked Questions

Where is NeuroDerm Ltd.'s headquarters located?

Minus sign iconPlus sign icon
NeuroDerm Ltd.'s main headquarters is located at 3 Pekeris Street Reẖovot, Central District Israel. The company has employees across 4 continents, including AsiaEuropeNorth America.

What is NeuroDerm Ltd.'s phone number?

Minus sign iconPlus sign icon
You can contact NeuroDerm Ltd.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NeuroDerm Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
NeuroDerm Ltd.'s official website is neuroderm.com and has social profiles on LinkedInCrunchbase.

What is NeuroDerm Ltd.'s SIC code NAICS code?

Minus sign iconPlus sign icon
NeuroDerm Ltd.'s SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NeuroDerm Ltd. have currently?

Minus sign iconPlus sign icon
As of March 2026, NeuroDerm Ltd. has approximately 165 employees across 4 continents, including AsiaEuropeNorth America. Key team members include Chief Executive Officer: K. I.Chief Technology Officer: U. D.Vp Human Resources: A. N.. Explore NeuroDerm Ltd.'s employee directory with LeadIQ.

What industry does NeuroDerm Ltd. belong to?

Minus sign iconPlus sign icon
NeuroDerm Ltd. operates in the Pharmaceutical Manufacturing industry.

What technology does NeuroDerm Ltd. use?

Minus sign iconPlus sign icon
NeuroDerm Ltd.'s tech stack includes Cloudflare CDNMySQLApple iCloud MailTwemojiyepnope.jsSwiperWhatsApp BusinessPWA.

What is NeuroDerm Ltd.'s email format?

Minus sign iconPlus sign icon
NeuroDerm Ltd.'s email format typically follows the pattern of First@neuroderm.com. Find more NeuroDerm Ltd. email formats with LeadIQ.

How much funding has NeuroDerm Ltd. raised to date?

Minus sign iconPlus sign icon
As of March 2026, NeuroDerm Ltd. has raised $75M in funding. The last funding round occurred on Dec 07, 2016 for $75M.

When was NeuroDerm Ltd. founded?

Minus sign iconPlus sign icon
NeuroDerm Ltd. was founded in 2003.

NeuroDerm Ltd.

Pharmaceutical ManufacturingCentral District, Israel51-200 Employees

NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.

By developing next-generation drug-device combination solutions for central nervous system disorders, we aspire to make a meaningful difference in patients’ lives and drive future healthcare connectivity.

Our mission is to address the challenges of the future healthcare and wellbeing ecosystem. We are passionately driven to reduce disease burden and improve the quality of life of patients and their families through innovative drug-device combination therapies and technologies.

Section iconCompany Overview

Headquarters
3 Pekeris Street Reẖovot, Central District Israel
Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
51-200

Section iconFunding & Financials

  • $75M

    NeuroDerm Ltd. has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Dec 07, 2016 in the amount of $75M.

  • $50M$100M

    NeuroDerm Ltd.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $75M

    NeuroDerm Ltd. has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Dec 07, 2016 in the amount of $75M.

  • $50M$100M

    NeuroDerm Ltd.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.